Please login to the form below

Not currently logged in
Email:
Password:

Yescarta

This page shows the latest Yescarta news and features for those working in and with pharma, biotech and healthcare.

Kite and Oxford BioTherapeutics sign oncology research pact

Kite and Oxford BioTherapeutics sign oncology research pact

The main focus of that deal was Kite’s Yescarta (axicabtagene ciloleucel), the company’s first CAR-T therapy, which was approved in October 2017 for the treatment of adults with ... Yescarta was joined by Kite’s second CAR-T therapy Tecartus

Latest news

More from news
Approximately 12 fully matching, plus 53 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics